title: [Celiac disease and the evolution of its diagnosis. Comparison and experience at a hospital pediatric department (1975-1993). (Second part)].
abstract: In a period of over 18 years the prominent medical bibliographic marks with regard to definition, diagnosis and examinations of coeliac disease (CD) have been compared and as far as possible reproduced. The results confirm the remarks derivating from wider statistics. From the beginning of 1975 to the first six months of 1993 in Merate Hospital Pediatric Division, 323 patients were submitted to a first jejunal peroral biopsy in 133 cases (41.2%) CD was diagnosed. Since 34 children (25.6%) concluded the ESPGAN diagnostic iter with 3 consecutive biopsies, the reasons why the other patients didn't finish or respect the programs are here examined. Since 1987 a specific anti-gliadin (IgA and IgG) antibodies titrimetry has been available either in the investigation of suspect symptomatology or like control mark during the assessment or after a sure CD diagnosis. Since october 1992 antiendomysium antibodies (EMA or AEA IgA) have been determined only in selected patients. From the examination of 24 subjects now checked with AGA IgA/IgG and EMA and with a first positive biopsy, it is possible to point out that only one jejunal biopsy (or at the most a second one as a control during the gluten challenge) with the guarantee of haematologic patterns doesn't raise doubts about a CD diagnosis. Analogous considerations mainly refer to the atypical CD "late onset" when a constant lack of AGA and EMA during gluten free diet (GFD) or their changes in a non compliance or in gluten challenge, can exclude a following hystological confirmation. By this experience it follows that a specific antigliadin and antiendomysium antibodies investigation is indispensable to the shortening of diagnostic times, to the reduction of an often unwelcome invasive diagnostic method and to the discovery of the "CD iceberg".
authors.affiliation: Divisione Pediatrica, Ospedale Provinciale S. Leopoldo Mandic, USSL 14, Merate, CO.
authors.forename: M A
authors.initials: MA
authors.lastname: Della Morte
authors.forename: M R
authors.initials: MR
authors.lastname: Sala
authors.forename: P
authors.initials: P
authors.lastname: Morelli
authors.forename: V
authors.initials: V
authors.lastname: Meschi
authors.forename: A
authors.initials: A
authors.lastname: Silva
authors.forename: B
authors.initials: B
authors.lastname: Colombo
authors.forename: F
authors.initials: F
authors.lastname: Malvezzi
authors.forename: F
authors.initials: F
authors.lastname: Cogliati
authors.forename: M
authors.initials: M
authors.lastname: Mancosu
authors.forename: F
authors.initials: F
authors.lastname: Valli
mesh_terms: D000293:Adolescent; D000328:Adult; D001706:Biopsy; D002446:Celiac Disease / Q000097:blood / Q000175:diagnosis*; D002648:Child; D002675:Child, Preschool; D004386:Duodenum / Q000473:pathology; D005260:Female; D005903:Gliadin / Q000276:immunology; D006748:Hospital Departments; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007223:Infant; D007583:Jejunum / Q000473:pathology; D008297:Male; D013997:Time Factors
chemical_list: D007136:Immunoglobulins; D005903:Gliadin
vernacular_title: La malattia celiaca e l'evoluzione nella sua diagnosi. Confronti ed esperienze di un reparto pediatrico ospedaliero (1975-1993). (Seconda parte).